Literature DB >> 11068090

A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation.

S Nekhai1, D P Bottaro, G Woldehawariat, A Spellerberg, R Petryshyn.   

Abstract

The double-stranded RNA dependent protein kinase (PKR) is a negative regulator of cell proliferation and thus itself a target for modulation. We show that a cell-permeable peptide (PRI), containing a conserved double-stranded RNA binding motif found in PKR, inhibits activation of the kinase and activity to phosphorylate its substrate. Further, the PRI-peptide localizes to the cytoplasm of murine embryonic fibroblasts and ablates cellular PKR activation. The PRI-peptide enhances cell proliferation compared to treatment with a variant control peptide, resulting in cultures with increased cell density. We conclude that peptides that interfere with PKR may be useful tools for regulating cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068090     DOI: 10.1016/s0196-9781(00)00297-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1.

Authors:  Marina Jerebtsova; Sergei A Klotchenko; Tatiana O Artamonova; Tatiana Ammosova; Kareem Washington; Vladimir V Egorov; Aram A Shaldzhyan; Maria V Sergeeva; Evgeny A Zatulovskiy; Olga A Temkina; Mikhail G Petukhov; Andrei V Vasin; Mikhail A Khodorkovskii; Yuri N Orlov; Sergei Nekhai
Journal:  Mol Cell Biochem       Date:  2010-10-13       Impact factor: 3.396

2.  Hepatitis C virus controls interferon production through PKR activation.

Authors:  Noëlla Arnaud; Stéphanie Dabo; Patrick Maillard; Agata Budkowska; Katerina I Kalliampakou; Penelope Mavromara; Dominique Garcin; Jacques Hugon; Anne Gatignol; Daisuke Akazawa; Takaji Wakita; Eliane F Meurs
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

3.  Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.

Authors:  Anne Cachat; Sébastien Alain Chevalier; Sandrine Alais; Nga Ling Ko; Lee Ratner; Chloé Journo; Hélène Dutartre; Renaud Mahieux
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

4.  Iron chelators ICL670 and 311 inhibit HIV-1 transcription.

Authors:  Zufan Debebe; Tatyana Ammosova; Marina Jerebtsova; Joseph Kurantsin-Mills; Xiaomei Niu; Sharroya Charles; Des R Richardson; Patricio E Ray; Victor R Gordeuk; Sergei Nekhai
Journal:  Virology       Date:  2007-07-13       Impact factor: 3.616

5.  Hepatitis C virus reveals a novel early control in acute immune response.

Authors:  Noëlla Arnaud; Stéphanie Dabo; Daisuke Akazawa; Masayoshi Fukasawa; Fumiko Shinkai-Ouchi; Jacques Hugon; Takaji Wakita; Eliane F Meurs
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

6.  Peptide inhibition of the SETD6 methyltransferase catalytic activity.

Authors:  Michal Feldman; Dan Levy
Journal:  Oncotarget       Date:  2017-12-21

Review 7.  dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.

Authors:  Stéphanie Dabo; Eliane F Meurs
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.